Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Mittapalli RK"'
Autor:
Yap TA; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston. Electronic address: TYap@mdanderson.org., Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston., Hamilton E; Breast and Gynecologic Research Program, Sarah Cannon Research Institute, Nashville., Rosen LS; UCLA Hematology-Oncology, Santa Monica., Stratton KL; Department of Urology, The University of Oklahoma Health Sciences Center & The Stephenson Cancer Center, Oklahoma City., Gordon MS; HonorHealth Research Institute, Scottsdale., Schaer D; Oncology Translational Science, Pfizer, Pearl River., Liu L; Oncology Translational Science, Pfizer, San Diego., Zhang L; Oncology Research Unit, Pfizer, Inc., San Diego., Mittapalli RK; Clinical Pharmacology, Pfizer Inc., San Diego., Zhong W; Oncology Biostatistics, Pfizer, Cambridge., Soman N; Clinical Research, Pfizer, Thousand Oaks., Tolcher AW; Clinical Research, NEXT Oncology, San Antonio, USA.
Publikováno v:
ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103653. Date of Electronic Publication: 2024 Aug 29.
Autor:
Leach MW; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Rana P; Pfizer Inc., 445 Eastern Point Road, Groton, CT 06340, USA. Electronic address: payal.m.rana@pfizer.com., Hu W; Pfizer Inc., 10777 Science Center Dr, San Diego, CA 92121, USA., Mittapalli RK; Pfizer Inc., 10777 Science Center Dr, San Diego, CA 92121, USA., Pinkstaff J; Pfizer Inc., 10777 Science Center Dr, San Diego, CA 92121, USA., Potter D; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Qiu XM; Pfizer Inc., Lane 60 Naxian Road, Shanghai 201203, China., Ramaiah L; Pfizer Inc., 401 N Middletown Road, Pearl River, NY 10965, USA., Rohde C; Pfizer Inc., 401 N Middletown Road, Pearl River, NY 10965, USA., Xia F; Pfizer Inc., 66 Hudson Boulevard, New York, NY 10001, USA., Khan KN; Pfizer Inc., 445 Eastern Point Road, Groton, CT 06340, USA.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Mar; Vol. 484, pp. 116854. Date of Electronic Publication: 2024 Feb 10.
Autor:
Zhou L; Clinical Pharmacology, Oncology Research and Development, Pfizer Inc., San Diego, USA., Reddy MB; Clinical Pharmacology, Oncology Research and Development, Pfizer lnc., Boulder, USA., Mittapalli RK; Clinical Pharmacology, Oncology Research and Development, Pfizer Inc., San Diego, USA., Yang J; Clinical Pharmacology, Oncology Research and Development, Pfizer Inc., San Diego, USA., Yin D; Clinical Pharmacology, Oncology Research and Development, Pfizer Inc., San Diego, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jan; Vol. 115 (1), pp. 29-35. Date of Electronic Publication: 2023 Nov 20.
Autor:
Mittapalli RK; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. rajendar.mittapalli@pfizer.com., Guo C; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA., Drescher SK; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA., Yin D; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Sep; Vol. 90 (3), pp. 207-216. Date of Electronic Publication: 2022 Aug 14.
Autor:
Yu Y; Pfizer Inc, La Jolla, CA, USA., Lin J; Pfizer Inc, Groton, CT, USA., Muto C; Pfizer R&D Japan, Tokyo, Japan., Li Y; Pfizer R&D Japan, Tokyo, Japan., Mori Y; Pfizer R&D Japan, Tokyo, Japan., Mittapalli RK; Pfizer Inc, La Jolla, CA, USA., Tse S; Pfizer Inc, Groton, CT, USA., Liu J; Pfizer Investment Co., LTD, China., Ge BK; Pfizer Investment Co., LTD, China., Liu J; Pfizer Inc, Groton, CT, USA.
Publikováno v:
International journal of medical sciences [Int J Med Sci] 2021 Sep 24; Vol. 18 (16), pp. 3718-3727. Date of Electronic Publication: 2021 Sep 24 (Print Publication: 2021).
Autor:
Mittapalli RK; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. rajendar.mittapalli@pfizer.com., Yin D; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA., Beaupre D; Clinical Development, Early Oncology Development and Clinical Research, Pfizer Inc., San Diego, CA, USA., Palaparthy R; Clinical Pharmacology, Early Clinical Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Jan; Vol. 87 (1), pp. 23-30. Date of Electronic Publication: 2020 Nov 25.
Autor:
Mittapalli RK; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Stodtmann S; AbbVie Deutschland GmbH & Co KG, Clinical Pharmacology and Pharmacometrics, Ludwigshafen am Rhein, Germany., Friedel A; AbbVie Deutschland GmbH & Co KG, Clinical Pharmacology and Pharmacometrics, Ludwigshafen am Rhein, Germany., Menon RM; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Bain E; Oncology Development, AbbVie Inc, North Chicago, IL, USA., Mensing S; AbbVie Deutschland GmbH & Co KG, Clinical Pharmacology and Pharmacometrics, Ludwigshafen am Rhein, Germany., Xiong H; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2019 Sep; Vol. 59 (9), pp. 1225-1235. Date of Electronic Publication: 2019 Apr 16.
Autor:
Klünder B; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA., Mittapalli RK; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA., Mohamed MF; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA., Friedel A; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA., Noertersheuser P; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA., Othman AA; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, 1 North Waukegan Road, Bldg. AP31-3, North Chicago, IL, 60064, USA. ahmed.othman@abbvie.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2019 Aug; Vol. 58 (8), pp. 1045-1058.
Autor:
van der Biessen DAJ; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Gietema JA; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Jonge MJA; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Desar IME; Radboud University Medical Center, Nijmegen, The Netherlands., den Hollander MW; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dudley M; AbbVie Inc., North Chicago, IL, USA., Dunbar M; AbbVie Inc., North Chicago, IL, USA., Hetman R; AbbVie Inc., North Chicago, IL, USA., Serpenti C; AbbVie B.V, Hoofddorp, The Netherlands., Xiong H; AbbVie Inc., North Chicago, IL, USA., Mittapalli RK; AbbVie Inc., North Chicago, IL, USA., Timms KM; Myriad Genetics Inc., Salt Lake City, UT, USA., Ansell P; AbbVie Inc., North Chicago, IL, USA., Ratajczak CK; AbbVie Inc., North Chicago, IL, USA., Shepherd SP; AbbVie Inc., North Chicago, IL, USA., van Herpen CML; Radboud University Medical Center, Nijmegen, The Netherlands. carla.vanherpen@radboudumc.nl.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2018 Oct; Vol. 36 (5), pp. 828-835. Date of Electronic Publication: 2018 Jan 08.
Autor:
Goss GD; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Ontario, Canada., Vokes EE; Department of Medicine, University of Chicago, Chicago, Illinois., Gordon MS; HonorHealth Research Institute, Scottsdale, Arizona., Gandhi L; New York University Perlmutter Cancer Center, NYU Health, New York, New York., Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas., Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, Texas., Fischer JS; AbbVie, Inc, North Chicago, Illinois., Chu KL; AbbVie, Inc, North Chicago, Illinois., Ames WW; AbbVie, Inc, North Chicago, Illinois., Mittapalli RK; AbbVie, Inc, North Chicago, Illinois., Lee HJ; AbbVie, Inc, North Chicago, Illinois., Zeng J; AbbVie, Inc, North Chicago, Illinois., Roberts-Rapp LA; AbbVie, Inc, North Chicago, Illinois., Loberg LI; AbbVie, Inc, North Chicago, Illinois., Ansell PJ; AbbVie, Inc, North Chicago, Illinois., Reilly EB; AbbVie, Inc, North Chicago, Illinois., Ocampo CJ; AbbVie, Inc, North Chicago, Illinois., Holen KD; AbbVie, Inc, North Chicago, Illinois., Tolcher AW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.
Publikováno v:
Cancer [Cancer] 2018 May 15; Vol. 124 (10), pp. 2174-2183. Date of Electronic Publication: 2018 Mar 13.